e-learning
resources
Virtual 2020
Pre-Congress Content
Phenotypes of obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses
B. Csoma (Budapest, Hungary), A. Bikov (Budapest, Hungary), G. Szucs (Budapest, Hungary), V. Müller (Budapest, Hungary), Z. Lázár (Budapest, Hungary)
Source:
Virtual Congress 2020 – Phenotypes of obstructive diseases
Session:
Phenotypes of obstructive diseases
Session type:
E-poster session
Number:
1245
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Csoma (Budapest, Hungary), A. Bikov (Budapest, Hungary), G. Szucs (Budapest, Hungary), V. Müller (Budapest, Hungary), Z. Lázár (Budapest, Hungary). The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses. 1245
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Blood eosinophils and exacerbation rate in COPD patients over three years
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
The course of disease of patients who died from asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 217s
Year: 2003
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004
The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013
Underdiagnosis of COPD in hospitalized patients
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012
COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Source: Eur Respir J 2014; 44: 791-794
Year: 2014
Anemia in COPD patients with an exacerbation
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
The comparison of eosinophilic and non-eosinophilic stable COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Exacerbations of severe asthma in patients treated with mepolizumab
Source: Eur Respir J, 52 (6) 1801127; 10.1183/13993003.01127-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept